Compare WASH & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WASH | CRMD |
|---|---|---|
| Founded | 1800 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 682.2M | 509.9M |
| IPO Year | 1994 | 2009 |
| Metric | WASH | CRMD |
|---|---|---|
| Price | $32.54 | $6.73 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $30.25 | $14.67 |
| AVG Volume (30 Days) | 158.8K | ★ 1.5M |
| Earning Date | 04-20-2026 | 03-05-2026 |
| Dividend Yield | ★ 6.75% | N/A |
| EPS Growth | 266.26 | ★ 780.00 |
| EPS | ★ 2.71 | 2.04 |
| Revenue | $229,048,000.00 | ★ $311,709,000.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | $6.19 | N/A |
| P/E Ratio | $12.24 | ★ $3.28 |
| Revenue Growth | 127.57 | ★ 617.03 |
| 52 Week Low | $24.97 | $5.60 |
| 52 Week High | $37.08 | $17.43 |
| Indicator | WASH | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 44.88 | 47.74 |
| Support Level | $31.51 | $6.55 |
| Resistance Level | $37.08 | $7.44 |
| Average True Range (ATR) | 0.83 | 0.23 |
| MACD | 0.05 | 0.08 |
| Stochastic Oscillator | 50.47 | 67.54 |
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It offers a full range of financial services, including commercial banking, mortgage banking, personal banking, and wealth management and trust services, through its offices located in Rhode Island, Connecticut, and Massachusetts. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.